Treatment of hypophosphataemic rickets in childhood is best done by an endocrinologist or pediatric nephrologist who specializes in XLH. It also often involves input from an orthopaedic surgeon, physiotherapist and ideally all of these working together.
Traditionally phosphate supplements are given multiple times a day. This is to allow enough phosphate in the body for the bones to heal and mineralise. Alongside phosphate supplements, an active form of vitamin D called Calcitriol is given.
A new medication called Burosumab was approved in 2018 by the USFDA and is now routinely used in children in several countries in North America and Europe.
Currently, Burosumab is unavailable for sale in India because of prohibitive costs.